Mississippi to reimburse for TTT of wet AMD

Mountain View, CA-Add Mississippi to the list of states whose Medicare administrators will pay for transpupillary thermother-apy (TTT) treatment of wet age-related macular degeneration (AMD).

Related Content:

Practice ManagementPediatrics

Managing neovascular retinal disease in COVID-19 era requires careful approach

Moving forward: Does science progress one funeral at a time?

Implementing COVID-19 safety protocols, guidelines in practice